Clinical Trial Update: The Prophet Trial -Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator (AFR) in Patients With Pulmonary Hypertension [NA]

View source ↗

Summary

A completed pilot trial assessing the safety and potential efficacy of Occlutech's Atrial Flow Regulator (AFR) in patients with pulmonary hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Drugs mentioned

• Atrial Flow Regulator (AFR) (atrial flow regulator)

Snippet

Sponsor: Occlutech International AB | Conditions: Pulmonary Hypertension | NA | Status: COMPLETED